MEBIAS Discovery
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3675 Market St Ste 200, Philadelphia, Pe...Phone Number
(267) 536-4125Website
www.mebiasdiscovery.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About MEBIAS Discovery
Mebias Discovery specializes in innovative drug discovery and development, focusing on G-protein coupled receptor (GPCR) signaling. Their proprietary membrane protein-NMR platform identifies drug candidates that minimize adverse effects while targeting GPCRs. The company is advancing its own molecules into early clinical development, including an Investigational New Drug for the mu-opioid receptor currently in Phase 1 studies, and Sphingosine 1-phosphate receptor agonists aimed at treating neuropathic pain and neuroinflammation.Explore more
MEBIAS Discovery Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MEBIAS Discovery your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at MEBIAS Discovery
Check out if MEBIAS Discovery is spiking on competitors!
Earning: See what the market has to say on MEBIAS Discovery recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if MEBIAS Discovery had a recent Job posting/layoffs
Funding: Get notified immidiatlly once MEBIAS Discovery has new funding data
MEBIAS Discovery, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when MEBIAS Discovery launches new products
Check if MEBIAS Discovery has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at MEBIAS Discovery
Find 2 more new buyers
Compare Similar Companies to MEBIAS Discovery
Compare insights from companies similar to MEBIAS Discovery, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MEBIAS Discovery is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MEBIAS Discovery is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MEBIAS Discovery.
MEBIAS Discovery financials insights
Gather financial insights about MEBIAS Discovery, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Other Financing Round
$3.5M
MEBIAS Discovery Tech Stack
A closer look at the technologies used by MEBIAS Discovery
See more technologies
MEBIAS Discovery News & Media
Mebias Discovery Closes $3.5M Funding Round
Mebias Discovery, a Philadelphia, PA-based leader in the field of drug discovery targeting G-protein coupled receptors (GPCR), closed a $3.5M funding round. The round was led by Viva Biotech Ltd. and Sprout BioVentures. The company intends to use the funds to expand its pipeline with new gastrointestinal (GI) and inflammation programs, applying its novel platform […] The post Mebias Discovery Closes $3.5M Funding Round appeared first on FinSMEs.MEBIAS Discovery Receives Grant from NIDA to Advance Its Signaling-Pathway Selective Mu-Opioid Receptor Drug Candidate
PHILADELPHIA--(BUSINESS WIRE)--MEBIAS Discovery Receives Grant from NIDA to Advance Its Signaling-Pathway Selective Mu-Opioid Receptor Drug Candidate.MEBIAS Discovery LLC Presents Pre-Clinical Data on Mu Opioid Receptor Pain Compounds at ADDC
PHILADELPHIA--(BUSINESS WIRE)--MEBIAS Discovery Presents Pre-clinical Data on biased Mu Opiod Pain Compounds showing absence of respiratory depression, addiction, other side effects
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MEBIAS Discovery
Sign Up For FreeTo access detailed company insights
Mebias Discovery specializes in innovative drug discovery and development, focusing on G-protein coupled receptor (GPCR) signaling. Their proprietary membrane protein-NMR platform identifies drug candidates that minimize adverse effects while targeting GPCRs. The company is advancing its own molecules into early clinical development, including an I... Read More
